 |
Email the Society |
 |
Donations |
ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
Mailing address:
GPO Box 383,
Adelaide,
South Australia 5001
Office:
266 Port Road,
Hindmarsh,
South Australia 5007
Ph: (08) 8346 3237
('834 MECFS')
Office Hours:
Wednesdays, 10am-3pm
Support Line:
(Mondays and Thursdays,
10am-3pm)
Ph: (08) 8346 3237
SA country callers:
Ph: 1300 128 339
(local call)
FIBROMYALGIA HELP: Contact Fibromyalgia SA at the Arthritis Foundation of SA 118 Richmond Road, Marleston 5033 Ph: (08) 8379 5711 |
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
|
Disclaimer
ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
| Become a Member | |||
|
The case for ribose
Tuesday 13 January 2009
Quite a few articles have popped up on the Web that discuss the benefits of ribose (also called deoxyribose or D-Ribose) for reducing many of the symptoms of ME/CFS and Fibromyalgia.
Most of the articles centre on the efforts of Dr Jacob Teitelbaum and his ribose studies.
For example, there’s this article from PRNewswire.
The article starts off talking about a book entitled You: Being Beautiful:The Owner's Manual to Inner and Outer Beauty and its advocacy of ribose.
It then goes to mention Dr Teitelbaum. A notable passage from the article is this:
“Dr. Teitelbaum's research published in the Journal of Alternative and Complementary Medicine (12:9, 2006), found a full two-thirds of his patients reported improvement of their symptoms in the first 12 days following a course of Corvalen® D-Ribose treatment. The average improvement in energy was 45 percent and quality of life improved an average of 30 percent. Patients reported less muscle soreness and stiffness, better ability to overcome fatigue, as well as simply feeling better.”
The article also mentions Bioenergy, Inc., a company specialising in D-Ribose and the producer of Corvalen®.
Dr Teitelbaum’s study can be found here: The Use of D-Ribose in Chronic Fatigue Syndrome and Fibromyalgia: A Pilot Study.
You can read more about the use of ribose for ME/CFS and Fibromyalgia in these articles: Chronic Fatigue Treatments: D-Ribose; and MedScape: Benefit of Ribose in a Patient With Fibromyalgia.
blog comments powered by Disqus
Previous Page |
